Table 6.
N = 2030 | OR for Albuminuria (ACR > 30) | OR for reduced eGFR (eGFR < 60) | Global test for significance | p-value for equality between albuminuria OR and reduced eGFR OR |
---|---|---|---|---|
Smoking Status | <0.001 | 0.02 | ||
Current Smoker vs never | 1.63* | 0.51** | ||
Former Smoker vs never | 1.42** | 1.02 | ||
Non-coronary Artery Disease | 1.36* | 1.35* | 0.006 | 0.95 |
Lower extremity ulcer | 2.97** | 1.25 | 0.01 | 0.06 |
Systolic BP, per 10 mmHG increase | 1.32*** | 1.03 | <0.001 | <0.001 |
Number of Hypertension Drug Classes, per 1 drug class increase | 1.43*** | 1.36*** | <0.001 | 0.52 |
Duration of Diabetes, per 5 years | 1.14*** | 1.23*** | <0.001 | 0.11 |
Diabetes Drugs | <0.001 | 0.001 | ||
2 or more drug classes vs 0,1 drug class | 1.57** | 0.80 | ||
Insulin vs 0,1 drug classes | 1.82*** | 1.12 | ||
HgbA1c per 1% increase | 1.19*** | 0.81*** | <0.001 | <0.001 |
HDL, per 5 mg/dl increase | 1.04 | 0.95 | 0.13 | 0.04 |
Ln(Triglycerides) | 1.43*** | 1.27* | <0.001 | 0.41 |
LV Ejection Fraction | ||||
Abnormal (EF < 50%) | 1.42* | 1.48** | 0.004 | 0.84 |
Abbreviations: eGFR (estimated glomerular filtration rate), LV (left ventricular), OR(odds ratio)
Model also included age, race/ethnicity, and gender for the albuminuria outcome. An indicator variable for missing LV Ejection Fraction was also included.
p <0.05,
p < 0.01,
p < 0.001